Mini Review
Volume 3 Issue 9 - 2020
Anatomic Approaches for Cancer Metastatic Study
Da-Yong Lu1*, Ying Shen2, Bin Xu3 and Ting-Ren Lu4
1School of Life Sciences, Shanghai University, Shanghai, China
2Medical School, Shanghai Jiao-Tong University, Shanghai, China
3Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
4College of Science, Shanghai University, Shanghai, China
*Corresponding Author: Da-Yong Lu, School of Life Sciences, Shanghai University, Shanghai, China.
Received: April 06, 2020; Published: August 31, 2020


The clinical incidence of cancer continues to grow worldwide (Approximately 19 million new incidence annually). Half of cancer patients can survive normally despite of cancer occurrence. However, another half cancer patient dies within 5 years mostly due to neoplasm metastasis. The pathologic and pharmacological significance for neoplasm metastasis is enormous. This editorial addresses one of the most important approaches for neoplasm metastatic study.

Keywords: Neoplasm Metastasis; Pharmacology; Anatomy; Mathematics


  1. Bray F., et al. “Global cancer statistics 2018; CLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries”. CA: A Cancer Journal for Clinicians6 (2018): 394-424.
  2. Lu DY., et al. “Anticancer drug development, a matter of money or a matter of idea?” Metabolomics2 (2015): e134.
  3. Mina LA and Sledge GW. “Rethinking the metastatic cascade as a therapeutic target”. Nature Reviews Clinical Oncology 6 (2011): 325-332.
  4. Lu DY and Lu TR. “Antimetastatic activities and mechanisms of bisdioxopiperazine compounds”. Anti-Cancer Agent Medicinal Chemistry7 (2010): 564-570.
  5. Lu DY., et al. “Cancer metastases and clinical therapies”. Cell and Developmental Biology4 (2012): e110.
  6. Lu DY., et al. “Cancer Metastasis treatments”. Current Drug Therapy1 (2013): 24-29.
  7. Gupta GP and Massague J. “Cancer metastasis: building a framework”. Cell 127 (2006): 679-695.
  8. Talmadge JE and Fidler IJ. “The biology of cancer metastasis: historical perspective”. Cancer Research 14 (2010): 5649-5669.
  9. Valastyan S and Weinberg RA. “Tumor metastasis: molecular insights and evolving paradigms”. Cell2 (2011): 275-292.
  10. Nieto MA., et al. “EMT”. Cell1 (2016): 21-45.
  11. Lambert AW., et al. “Emerging biological principles of metastasis”. Cell 168 (2017): 670-691.
  12. Lu DY and Cao JY. “Structural aberration of cellular sialic acids and their functions in cancer”. Journal of Shanghai University 2 (2001): 164-170.
  13. Lu DY., et al. “Development of antimetastatic drugs by targeting tumor sialic acids”. Scientia Pharmaceutica 3 (2012): 497-508.
  14. Lu DY., et al. “Antimetastatic therapy targeting aberrant sialylation profiles in cancer cells”. Drugs and Therapy Studies 1 (2011): e12.
  15. Bull C., et al. “Targeting aberrant sialylation in cancer cells using a fluorinated sialic acid analog impairs adhesion migration and In vivo tumor growth”. Molecular Cancer Therapeutics 12 (2013): 1935-1946.
  16. Freire-de-Lima L., et al. “Editorial: Glycosylation changes in cancer: An innovative frontier at the interface of cancer and glycol-biology”. Frontiers in Oncology 6 (2016): 254.
  17. Vajaria BN., et al. “Sialylation: an avenue to target cancer cells”. Pathology and Oncology Research 3 (2016): 443-447.
  18. Lu DY., et al. “Relationship between blood fibrinogen concentration and pathological features of cancer patients: a 139-case clinical study”. Journal of Biological Sciences 1 (2007): 8-11.
  19. Lu DY., et al. “Treatment of solid tumors and metastases by fibrinogen-targeted anticancer drug therapy”. Medical Hypotheses 1 (2007): 188-193.
  20. Dvorak HF. “Tumor stroma, tumor blood vessels, and anti-angiogenesis therapy”. Journal Cancer 4 (2015): 237-243.
  21. Dvorak HF., et al. “Tumor micro-environment and progression”. Journal of Surgical Oncology6 (2011): 468-474.
  22. Lu DY., et al. “Cancer metastasis, a clinical dilemma for therapeutics”. Current Drug Therapy2 (2016): 163-169.
  23. Lu DY., et al. “Anticancer drug combination, how far we can go through?” Anti-Cancer Agents in Medicinal Chemistry 1 (2017): 21-28.
  24. Lu DY., et al. “Drug combination in clinical cancer treatment”. Reviews on Recent Clinical Trials 3 (2017): 202-211.
  25. Zhu H., et al. “Upregulating Noxa by ER stress, celastrol exerts synergistic anticancer activity in combination with ABT-737 in human hepatocellular carcinoma cells”. Plos One 12 (2012): e52333.
  26. Gerlee P and Johanson M. “Infering rates of metastatic dissemination using stochastic network models”. PLOS Computational Biology4 (2019): e1006868.
  27. Franssen LC., et al. “A mathematical framework for modeling the metastatic spread of cancer”. Bulletin Mathematical Biology 81 (2019): 1965-2011.
  28. Tian XL., et al. “CRISPR/Cas9-An evolving biological tool kid for cancer biology and oncology”. NPJ Precision Oncology 3 (2019): 8.
  29. Lu DY., et al. “Anticancer drug developments, challenge from historic perspective”. EC Pharmacology and Toxicology11 (2018): 922-936.
  30. Lu DY., et al. “Anti-metastatic drug development, work out towards new direction”. Medicinal Chemistry7 (2018): 192-196.
  31. Lu DY., et al. “Keep up the pace of drug development evolution and expenditure”. Cancer Treatment Reviews 5 (2018): 165.
Citation: Da-Yong Lu., et al. “Anatomic Approaches for Cancer Metastatic Study”. EC Clinical and Experimental Anatomy 3.9 (2020): 32-34.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

December Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 21, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.